3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
7
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Gastric Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Liver Diseases
1
Leukemia, Myeloid, Acute
1
Immune Checkpoint Inhibition
1
ESCC
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Bites and Stings
1
Advanced Hepatocellular Carcinoma
1
Interventions
sintilimab
1
pembrolizumab
1
camrelizumab
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Colonoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Turcot syndrome
×
camrelizumab
×
Clear all
NCT06215677
2025-09-05
NITDC
Peking Union Medical College Hospital
Phase NA
Recruiting
18 enrolled